NCT02454075 2021-01-29
YF476 and Type II Gastric Carcinoids
Trio Medicines Ltd.
Phase 2 Terminated
Clinical Trials
4 trialsNCT02153398 2017-01-19
A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases
AstraZeneca
Phase 3 Completed
NCT00942175 2012-02-03
A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.
Takeda
Phase 1 Completed
NCT00079833 2010-11-19
Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome
AstraZeneca
Phase 3 Completed